N G Industries Share Price
Sector: Healthcare Facilities
164.50 +6.75 (4.28%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
159.05
Today’s High
165.00
52 Week Low
145.00
52 Week High
205.50
Key Metrics
- Market Cap (In Cr) 55.11
- Beta 0.13
- Div. Yield (%) 2.14
- P/B 1.52
- TTM P/E 4.98
- Sector P/E 22.75
- Open Price 165
- Prev Close 157.75
N G Industries Analysis
Price Analysis
-
1 Week0.77%
-
3 Months1.58%
-
6 Month-3.25%
-
YTD-9.06%
-
1 Year4.94%
Risk Meter
- 38% Low risk
- 38% Moderate risk
- 38% Balanced Risk
- 38% High risk
- 38% Extreme risk
N G Industries News
Premji Foundation, Tata Trusts match social spending of top Nifty companies
3 min read . 05:45 AM ISTBelrise Industries IPO subscribed 67% on Day 1; Check GMP, other details
2 min read . 21 May 2025Belrise Industries IPO Day 1: GMP, subscription status, review, other details
3 min read . 21 May 2025N G Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 16.88
- Selling/ General/ Admin Expenses Total
- 2.13
- Depreciation/ Amortization
- 0.6
- Other Operating Expenses Total
- 8.43
- Total Operating Expense
- 15.52
- Operating Income
- 1.36
- Net Income Before Taxes
- 5.85
- Net Income
- 5.03
- Diluted Normalized EPS
- 15.01
- Period
- 2024
- Total Assets
- 39.92
- Total Liabilities
- 3.79
- Total Equity
- 36.14
- Tangible Book Valueper Share Common Eq
- 107.84
- Period
- 2024
- Cashfrom Operating Activities
- -1.02
- Cashfrom Investing Activities
- 2.25
- Cashfrom Financing Activities
- -0.6
- Net Changein Cash
- 0.63
- Period
- 2023
- Total Revenue
- 18.7
- Selling/ General/ Admin Expenses Total
- 2.12
- Depreciation/ Amortization
- 0.52
- Other Operating Expenses Total
- 7.94
- Total Operating Expense
- 17.42
- Operating Income
- 1.29
- Net Income Before Taxes
- 9.65
- Net Income
- 8.32
- Diluted Normalized EPS
- 24.79
- Period
- 2023
- Total Assets
- 30.72
- Total Liabilities
- 2.52
- Total Equity
- 28.2
- Tangible Book Valueper Share Common Eq
- 84.16
- Period
- 2023
- Cashfrom Operating Activities
- 3.16
- Cashfrom Investing Activities
- -1.72
- Cashfrom Financing Activities
- -1.11
- Net Changein Cash
- 0.33
- Period
- 2022
- Total Revenue
- 18.42
- Selling/ General/ Admin Expenses Total
- 9.56
- Depreciation/ Amortization
- 0.58
- Total Operating Expense
- 16.71
- Operating Income
- 1.71
- Net Income Before Taxes
- 3.32
- Net Income
- 2.61
- Diluted Normalized EPS
- 7.79
- Period
- 2022
- Total Assets
- 27.15
- Total Liabilities
- 3.24
- Total Equity
- 23.91
- Tangible Book Valueper Share Common Eq
- 71.33
- Period
- 2022
- Cashfrom Operating Activities
- -1.73
- Cashfrom Investing Activities
- 1.26
- Cashfrom Financing Activities
- 0.22
- Net Changein Cash
- -0.25
- Period
- 2021
- Total Revenue
- 11.88
- Selling/ General/ Admin Expenses Total
- 7.47
- Depreciation/ Amortization
- 0.49
- Total Operating Expense
- 11.17
- Operating Income
- 0.71
- Net Income Before Taxes
- 0.83
- Net Income
- 0.61
- Diluted Normalized EPS
- 1.83
- Period
- 2021
- Total Assets
- 16.84
- Total Liabilities
- 1.83
- Total Equity
- 15.01
- Tangible Book Valueper Share Common Eq
- 44.73
- Period
- 2021
- Cashfrom Operating Activities
- 1.35
- Cashfrom Investing Activities
- 2
- Cashfrom Financing Activities
- -2.78
- Net Changein Cash
- 0.57
- Period
- 2020
- Total Revenue
- 18.5
- Selling/ General/ Admin Expenses Total
- 10.94
- Depreciation/ Amortization
- 0.56
- Total Operating Expense
- 16.34
- Operating Income
- 2.16
- Net Income Before Taxes
- 2.03
- Net Income
- 1.47
- Diluted Normalized EPS
- 4.38
- Period
- 2020
- Total Assets
- 13.92
- Total Liabilities
- 4.58
- Total Equity
- 9.34
- Tangible Book Valueper Share Common Eq
- 27.78
- Period
- 2020
- Cashfrom Operating Activities
- 2.85
- Cashfrom Investing Activities
- -3.41
- Cashfrom Financing Activities
- 0.27
- Net Changein Cash
- -0.29
- Period
- 2019
- Total Revenue
- 17.67
- Selling/ General/ Admin Expenses Total
- 10.19
- Depreciation/ Amortization
- 0.57
- Total Operating Expense
- 15.5
- Operating Income
- 2.17
- Net Income Before Taxes
- 1.73
- Net Income
- 1.12
- Diluted Normalized EPS
- 3.36
- Period
- 2019
- Total Assets
- 13.32
- Total Liabilities
- 2.34
- Total Equity
- 10.97
- Tangible Book Valueper Share Common Eq
- 32.58
- Period
- 2019
- Cashfrom Operating Activities
- 3.82
- Cashfrom Investing Activities
- -1.09
- Cashfrom Financing Activities
- -1.75
- Net Changein Cash
- 0.99
- Period
- 2024-12-31
- Total Revenue
- 4
- Selling/ General/ Admin Expenses Total
- 1.78
- Depreciation/ Amortization
- 0.16
- Other Operating Expenses Total
- 0.73
- Total Operating Expense
- 3.75
- Operating Income
- 0.25
- Net Income Before Taxes
- 7.91
- Net Income
- 6.71
- Diluted Normalized EPS
- 20.03
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 4.38
- Selling/ General/ Admin Expenses Total
- 1.9
- Depreciation/ Amortization
- 0.15
- Other Operating Expenses Total
- 0.88
- Total Operating Expense
- 4.08
- Operating Income
- 0.31
- Net Income Before Taxes
- 3.49
- Net Income
- 2.97
- Diluted Normalized EPS
- 8.85
- Period
- 2024-09-30
- Total Assets
- 48.44
- Total Liabilities
- 6.73
- Total Equity
- 41.71
- Tangible Book Valueper Share Common Eq
- 119.17
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 3.63
- Cashfrom Investing Activities
- -2.33
- Cashfrom Financing Activities
- -1.12
- Net Changein Cash
- 0.18
- Period
- 2024-06-30
- Total Revenue
- 3.7
- Selling/ General/ Admin Expenses Total
- 1.68
- Depreciation/ Amortization
- 0.14
- Other Operating Expenses Total
- 0.73
- Total Operating Expense
- 3.45
- Operating Income
- 0.25
- Net Income Before Taxes
- 0.57
- Net Income
- 0.5
- Diluted Normalized EPS
- 1.48
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 4.07
- Selling/ General/ Admin Expenses Total
- 0.46
- Depreciation/ Amortization
- 0.13
- Other Operating Expenses Total
- 2
- Total Operating Expense
- 3.68
- Operating Income
- 0.39
- Net Income Before Taxes
- 2.26
- Net Income
- 1.94
- Diluted Normalized EPS
- 5.8
- Period
- 2024-03-31
- Total Assets
- 39.92
- Total Liabilities
- 3.79
- Total Equity
- 36.14
- Tangible Book Valueper Share Common Eq
- 107.84
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -1.02
- Cashfrom Investing Activities
- 2.25
- Cashfrom Financing Activities
- -0.6
- Net Changein Cash
- 0.63
- Period
- 2023-12-31
- Total Revenue
- 3.95
- Selling/ General/ Admin Expenses Total
- 1.84
- Depreciation/ Amortization
- 0.18
- Other Operating Expenses Total
- 0.71
- Total Operating Expense
- 3.72
- Operating Income
- 0.23
- Net Income Before Taxes
- 0.48
- Net Income
- 0.43
- Diluted Normalized EPS
- 1.27
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
N G Industries Technical
Moving Average
SMA
- 5 Day160.05
- 10 Day159.26
- 20 Day160.88
- 50 Day164.71
- 100 Day168.1
- 300 Day169.58
N G Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Fortis Malar Hospitals
- 74.7
- 0.31
- 0.42
- 98.7
- 51.01
- 140
- Aspira Pathlab & Diagnostics
- 61.6
- 2.9
- 4.94
- 106.78
- 25
- 63.41
- N G Industries
- 164.5
- 6.75
- 4.28
- 205.5
- 145
- 55.11
- Tejnaksh Healthcare
- 22.25
- 0.61
- 2.82
- 30.5
- 20.5
- 45.4
- Medinova Diagnostic Services
- 39.25
- -0.08
- -0.2
- 51.05
- 32.1
- 39.18
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Fortis Malar Hospitals
- 18.17
- 1.27
- 1.1
- 1.17
- Aspira Pathlab & Diagnostics
- -
- 5.96
- -2.56
- -1.64
- N G Industries
- 10.51
- 1.46
- 18.04
- 21.38
- Tejnaksh Healthcare
- 24.87
- 1.87
- 11.13
- 16.21
- Medinova Diagnostic Services
- 20.81
- -
- -
- 17.61
N G Industries Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results & Final Dividend
- 11-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Dividend
- 13-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results & Dividend
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Sept-24
- 17-Sept-24
- AGM
- 30-Sept-23
- 23-Aug-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-24
- -
- 20-Sept-24
- 3.5
- 19-May-23
- -
- 22-Sept-23
- 3.5
- 27-May-22
- -
- 16-Sept-22
- 3.5


